2004
DOI: 10.2337/diabetes.53.2.366
|View full text |Cite
|
Sign up to set email alerts
|

Gene Expression Profiles Define a Key Checkpoint for Type 1 Diabetes in NOD Mice

Abstract: ShecDNA microarrays with >11,000 cDNA clones from an NOD spleen cDNA library were used to identify temporal gene expression changes in NOD mice (1-10 weeks), which spontaneously develop type 1 diabetes, and changes between NOD and NOD congenic mice (NO-D.Idd3/Idd10 and NOD.B10Sn-H2 b ), which have near zero incidence of insulitis and diabetes. The expression profiles identified two distinct groups of mice corresponding to an immature (1-4 weeks) and mature (6 -10 weeks) state. The rapid switch of gene expressi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

5
28
2

Year Published

2004
2004
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 29 publications
(35 citation statements)
references
References 40 publications
5
28
2
Order By: Relevance
“…Furthermore, 4 wk is in line with the two previous diabetic heart gene expression array studies, which examined animals 2 wk post-streptozotocin (31) or 3 days, 4 wk, and 6 wk poststreptozotocin (19). The diabetic rats were not treated with insulin, similar to the majority of previous gene array studies of diabetic animals (2,11,13,18,33,35,50,51,58). Streptozotocin can produce diabetes with either intravenous or intraperitoneal administration; the latter was used in the present study on the basis of previous success with this approach (55,56).…”
Section: Discussionsupporting
confidence: 64%
See 2 more Smart Citations
“…Furthermore, 4 wk is in line with the two previous diabetic heart gene expression array studies, which examined animals 2 wk post-streptozotocin (31) or 3 days, 4 wk, and 6 wk poststreptozotocin (19). The diabetic rats were not treated with insulin, similar to the majority of previous gene array studies of diabetic animals (2,11,13,18,33,35,50,51,58). Streptozotocin can produce diabetes with either intravenous or intraperitoneal administration; the latter was used in the present study on the basis of previous success with this approach (55,56).…”
Section: Discussionsupporting
confidence: 64%
“…Examples of perturbed systems include protein degradation and ubiquitination, carbohydrate and lipid metabolism, nitrogen metabolism, transcription and translation, morphogenesis/organogenesis, extracellular matrix including collagen, and oxidative stress (2,11,13,18,34,35,50,51,58,61). However, there is considerable divergence among tissue types with regard to which of these systems are impacted by diabetes, as well as in the magnitude of the alterations for those systems that are affected, even for studies in which multiple tissues were examined simultaneously (31,50).…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…However, these cell lines cannot model the complexity of in vivo interactions among islets, exocrine pancreas, and the host immune response seen in T1DM. Other approaches include the use of NOD mice spleens to define key checkpoints for T1DM (16). Our data, on the other hand, provide a more global survey of gene modulation in vivo over a 20-wk period and indicate that insulitis is not a progressively increasing process but a relapsing and remitting one.…”
Section: Discussionmentioning
confidence: 82%
“…The DNA microarray approach has been applied to the study of diabetes. Examples of tissues examined include ␤-cells (5,36), immune cells or organs (7,38), adipose tissue (25), the retina (11), skeletal muscle (23,30,40), and the kidney or kidney cells (24,31,37). Many of these studies have provided novel insights into the pathophysiology of diabetes and identified previously unsuspected mechanisms deserving further investigation.…”
mentioning
confidence: 99%